Mark Meyers has held various high-level sales and business development positions in the technology and life sciences industries, working for companies like ACD/Labs, Chemspeed Technologies, VelQuest Corporation, Symyx Technologies, EraGen Biosciences, Scimagix, and Oxford Molecular. Mark holds multiple degrees from Loyola University Maryland in Computer Science, Computer Engineering, and Finance.
This person is not in any offices
Advanced Chemistry Development, Inc., (ACD/Labs)
Advanced Chemistry Development, Inc., (ACD/Labs) develops and commercialzes informatics solutions for chemical, biochemical, and pharmaceutical R&D. Our expertise lies in vendor-agnostic spectroscopic and chromatographic data processing and prediction, physicochemical and ADME-Tox property prediction, analytical knowledge management, interactive reporting, and integrating analytical data with chemical structures to help protect and leverage valuable research knowledge. ACD/Labs' solutions help scientists and their organizations to share and reuse accumulated knowledge more efficiently, to get products to market faster—the vital business necessity of our times. Serving customers since 1994, ACD/Labs has developed a number of industry leading software tools, including ACD/Structure Elucidator, an Automated Structure Verification solution, pKa property predictor, renowned ACD/Name chemical nomenclature software, ACD/AutoChrom, a MetID solution, a Biotransformation knowledge management package, not to mention our consistently popular NMR Processing and prediction software. ADMET predictive software and Structure Design and Lead Optimization tools have been added and augmented since the late 2000's. In recent years, the company delivered new informatics platforms-Percepta and Spectrus (www.acdlabs.com/percepta and www.acdlabs.com/spectrus)-to stay abreast of our customers' latest requirements.